Search results
Williams-Sonoma ordered to pay $3.1 million penalty for false 'Made in USA' labeling
United Press International via Yahoo Finance· 5 days agoThe Department of Justice said Friday that cookware company Williams-Sonoma will pay a $3 million...
The Biden Administration’s New Pro-Worker Rule Has Powerful Enemies
The New Republic via Yahoo Finance· 1 day ago“Noncompete clauses keep wages low, suppress new ideas, and rob the American economy of dynamism,...
Farmers fear higher prices, consolidation from Koch fertilizer plant purchase
Iowa Capital Dispatch via Yahoo News· 4 days agoNEVADA, Iowa — Harold Beach, a northeast Missouri farmer who runs a row-crop operation and raises...
Opinion | The FTC Decrees: No More Non-Compete Agreements
The Wall Street Journal· 7 days agoLina Khan’s latest rule instantly invalidates 30 million contracts without Congressional authority.
US FCC resumes full oversight of broadband service providers
Reuters· 1 day agoThe Federal Communications Commission (FCC) said on Tuesday it has terminated a 2017 memorandum of...
Sen. Warren blasts TurboTax for deceptive advertising: pushes for IRS Direct File program
Cape Cod Times via Yahoo Finance· 4 days agoDay April 15 to send a letter to the Federal Trade Commission criticizing Intuit Inc.’s TurboTax free tax filing program and urging Commission Chair Lina Khan< ...
Opinion | Biden’s FTC just exposed one of the GOP and businesses’ biggest lies to workers
MSNBC via Yahoo News· 6 days agoThese contracts, research shows, depress wages, stifle entrepreneurial innovation and trap people in...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 23 hours agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 23 hours ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 10 hours agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...